Total for the last 12 months
number of access : ?
number of downloads : ?
ID 118574
Author
Fujita, Kazutoshi Kindai University
Kimura, Go Nippon Medical School
Tsuzuki, Toyonori Aichi Medical University
Kato, Taigo Osaka University
Banno, Eri Kindai University
Kazama, Akira Niigata University
Yamashita, Ryo Shizuoka Cancer Center
Matsushita, Yuto Hamamatsu University School of Medicine
Ishii, Daisuke Kitasato University
Nakagawa, Yuki Chugai Pharmaceutical Co., Ltd.
Fukuyama, Tamaki Chugai Pharmaceutical Co., Ltd.
Sano, Fumikazu Chugai Pharmaceutical Co., Ltd.
Kondo, Yukihiro Nippon Medical School
Uemura, Hirotsugu Kindai University
Keywords
TIME (tumor immune microenvironment)
synchronous
metachronous
mRCC (metastatic renal cell carcinoma)
PD-L1
immunophenotype
Content Type
Journal Article
Description
The association between the tumor immune microenvironment (TIME) of primary lesions and time to metastasis remains unknown. The aim of our retrospective study was to investigate the differences in the TIME of primary lesions based on time intervals to metastasis, mainly between the synchronous group (SG; metastasis within 3 months) and metachronous group (MG; metastasis after 3 months), and its association with clinicopathological parameters in patients with metastatic renal cell carcinoma (mRCC). SG showed more immunogenic feature of TIME (PD-L1 positivity, CD8+ TIL infiltration) and poor prognostic pathological features (WHO/ISUP grade 4, necrosis, lymphovascular invasion, infiltrative growth pattern, and sarcomatoid differentiation). In addition, we observed that the time to metastasis differed by TIME characteristics (PD-L1 status, immunophenotype), which were associated with the WHO/ISUP grade. The TIME of primary lesions could affect the time to metastasis.
Description Alternative
Biological or immunological differences in primary lesions between synchronous and metachronous metastatic renal cell carcinoma (mRCC) have been reported. However, the association between the tumor immune microenvironment (TIME) of primary lesions and time to metastasis remains unknown. We investigated the differences in the TIME of primary lesions based on time intervals to metastasis, mainly between the synchronous group (SG; metastasis within 3 months) and metachronous group (MG; metastasis after 3 months), and its association with clinicopathological parameters in patients with mRCC. Overall, 568 patients treated first-line with vascular endothelial growth factor receptor inhibitors comprised the analysis population (SG: N = 307 [54.0%]; MG: N = 261 [46.0%]). SG had a higher proportion of patients with poor prognostic pathological feature tumors: WHO/ISUP grade 4, necrosis, lymphovascular invasion, infiltrative growth pattern, and sarcomatoid differentiation. Regarding the TIME, more immunogenic features were seen in SG than MG, with a higher PD-L1 positivity and a lower proportion of the desert phenotype. This is the first study to examine the differences in the TIME of primary lesions in patients with mRCC based on the time intervals to metastasis. The TIME of primary lesions could affect the time to metastasis.
Journal Title
Cancers
ISSN
20726694
Publisher
MDPI
Volume
14
Issue
21
Start Page
5258
Published Date
2022-10-26
Rights
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences